Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Agustina Roldan-Deamicis"'
Autor:
Roxana Schillaci, Sofia Bruni, Florencia Mauro, María F Mercogliano, Agustina Roldan-Deamicis, Cecilia J Proietti, Rosalía Cordo-Russo, Gloria Inurrigarro, Agustina Dupont, Carla Adami, Daniel Lopez Della Vecchia, Sabrina Barchuck, Silvina Figurelli, Ernesto Gil Deza, Sandra Ares, Felipe G Gercovich, Patricia V Elizalde
Publikováno v:
Cancer Research. 82:P5-13
Background HER2-positive (+) and triple negative breast cancer (TNBC) have the worst survival among BC. BC patients are treated with chemotherapy (CT) and/or radiotherapy (RT), and HER2+ BC patients also receive targeted therapies, such as trastuzuma
Autor:
Patricia Elizalde, Agustina Roldan Deamicis, Robert Oakley, Santiago Madera, Rosalía Cordo Russo, Roxana Schillaci, Cristóbal Fresno, John Cidlowski, Cecilia Proietti
Publikováno v:
Journal of the Endocrine Society. 6:A720-A720
Triple negative breast cancer (TNBC) has poor prognosis and neither established biomarkers nor therapeutic targets. On the one hand, the androgen receptor (AR), a steroid hormone receptor (SR) which is expressed in 10-53% of TNBC and proved to be cri
Autor:
Patricia Elizalde, Martina Belmonte, Mauro Cenciarini, Agustina Roldan Deamicis, Santiago Madera, Florencia Mercogliano, Florencia Mauro, Sofia Bruni, Rosalía Cordo Russo, Roxana Schillaci, Cecilia Proietti
Publikováno v:
Journal of the Endocrine Society. 6:A719-A719
Enhancer of Zeste homolog 2 (EZH2) is a histone methyltransferase which catalyzes the trimethylation of lysine 27 of histone H3 (H3K27me3), an epigenetic mark associated with chromatin compaction and transcriptional repression of target genes. This c
Publikováno v:
CONICET Digital (CONICET)
Consejo Nacional de Investigaciones Científicas y Técnicas
instacron:CONICET
Biology and Medicine. 201, 9(3)
Repositorio Institucional (UCA)
Pontificia Universidad Católica Argentina
instacron:UCA
Consejo Nacional de Investigaciones Científicas y Técnicas
instacron:CONICET
Biology and Medicine. 201, 9(3)
Repositorio Institucional (UCA)
Pontificia Universidad Católica Argentina
instacron:UCA
Conventional treatments for breast cancer involve surgery followed by radiation and hormonal therapy and/or chemotherapy. Some of these treatments have toxic side effects. Because drugs used in chemotherapy affect both cancer and normal cells to vary
Autor:
Eliana Noelia Alonso, Agustina Roldan-Deamicis, Belén Brie, Gabriela Andrea Balogh, Diego Aguilera Braico
Publikováno v:
Cancer Medicine. 2016, 5(9):2427–2441
Repositorio Institucional (UCA)
Pontificia Universidad Católica Argentina
instacron:UCA
CONICET Digital (CONICET)
Consejo Nacional de Investigaciones Científicas y Técnicas
instacron:CONICET
Cancer Medicine
Repositorio Institucional (UCA)
Pontificia Universidad Católica Argentina
instacron:UCA
CONICET Digital (CONICET)
Consejo Nacional de Investigaciones Científicas y Técnicas
instacron:CONICET
Cancer Medicine
The understanding of the molecular mechanisms of the immune tolerance induced by the tumoral microenvironment is fundamental to prevent cancer development or to treat cancer patients using immunotherapy. Actually, there are investigations about "addr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5f6c2cd33f1c78fa0c225ced7846f5cf
https://repositorio.uca.edu.ar/handle/123456789/14225
https://repositorio.uca.edu.ar/handle/123456789/14225